BR0015422A - Formulações de droga de liberação prolongada - Google Patents

Formulações de droga de liberação prolongada

Info

Publication number
BR0015422A
BR0015422A BR0015422-9A BR0015422A BR0015422A BR 0015422 A BR0015422 A BR 0015422A BR 0015422 A BR0015422 A BR 0015422A BR 0015422 A BR0015422 A BR 0015422A
Authority
BR
Brazil
Prior art keywords
particles
carbonate
substance
acid
active ingredient
Prior art date
Application number
BR0015422-9A
Other languages
English (en)
Other versions
BR0015422B1 (pt
Inventor
Akihiko Sano
Masako Kajihara
Hiroo Maeda
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of BR0015422A publication Critical patent/BR0015422A/pt
Publication of BR0015422B1 publication Critical patent/BR0015422B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçõES DE DROGA DE LIBERAçãO PROLONGADA". A presente invenção refere-se a uma formulação para implante tendo uma nova constituição, a qual realiza liberações controladas de ingredientes ativos. A formulação compreende uma das combinações (a), (b) e (c) bem como um carreador compreendendo um polímero hidrofóbico, onde a combinação de partícula é dispersa no carreador: (a) partículas compreendendo um ingrediente ativo, partículas compreendendo um carbonato e partículas compreendendo uma substância que é reagida com o carbonato em uma solução aquosa para gerar dióxido de carbono (substância tal como um ácido); (b) partículas compreendendo um ingrediente ativo e um carbonato, e partículas compreendendo uma substância tal como um ácido; e (c) partículas compreendendo um carbonato, e partículas compreendendo um ingrediente ativo e uma substância tal como um ácido.
BRPI0015422-9A 1999-11-10 2000-10-31 formulações de droga de liberação prolongada. BR0015422B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31910899 1999-11-10
PCT/JP2000/007639 WO2001034112A1 (en) 1999-11-10 2000-10-31 Sustained-release drug formulations for implantation

Publications (2)

Publication Number Publication Date
BR0015422A true BR0015422A (pt) 2002-07-16
BR0015422B1 BR0015422B1 (pt) 2012-09-04

Family

ID=18106562

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0015422-9A BR0015422B1 (pt) 1999-11-10 2000-10-31 formulações de droga de liberação prolongada.

Country Status (16)

Country Link
US (2) US7247312B1 (pt)
EP (1) EP1229900B1 (pt)
KR (1) KR100772948B1 (pt)
CN (1) CN1170523C (pt)
AT (1) ATE297714T1 (pt)
AU (1) AU778359B2 (pt)
BR (1) BR0015422B1 (pt)
CA (1) CA2384301C (pt)
DE (1) DE60020871T2 (pt)
ES (1) ES2243311T3 (pt)
MX (1) MXPA02004711A (pt)
NZ (1) NZ518252A (pt)
PT (1) PT1229900E (pt)
TW (1) TW524696B (pt)
WO (1) WO2001034112A1 (pt)
ZA (1) ZA200202402B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
EP1893130A4 (en) 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
WO2012027378A2 (en) * 2010-08-23 2012-03-01 President And Fellows Of Harvard College Particles for drug delivery and other applications

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US5417985A (en) * 1989-07-20 1995-05-23 Farmalyoc Solid and porous single dosage form comprising particles in the form of beads and its preparation
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
JP2818892B2 (ja) 1989-10-02 1998-10-30 大塚製薬 株式会社 発泡製剤
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
AU1354497A (en) * 1995-12-21 1997-07-14 Drexel University Hollow polymer microcapsules and method of producing
US6210715B1 (en) * 1997-04-01 2001-04-03 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations

Also Published As

Publication number Publication date
ZA200202402B (en) 2003-05-28
CA2384301C (en) 2009-05-12
US7601363B2 (en) 2009-10-13
EP1229900A1 (en) 2002-08-14
CN1170523C (zh) 2004-10-13
MXPA02004711A (es) 2002-09-02
ES2243311T3 (es) 2005-12-01
BR0015422B1 (pt) 2012-09-04
ATE297714T1 (de) 2005-07-15
CA2384301A1 (en) 2001-05-17
KR20020059617A (ko) 2002-07-13
KR100772948B1 (ko) 2007-11-02
US7247312B1 (en) 2007-07-24
AU778359B2 (en) 2004-12-02
EP1229900B1 (en) 2005-06-15
AU7963900A (en) 2001-06-06
US20070166377A1 (en) 2007-07-19
TW524696B (en) 2003-03-21
WO2001034112A1 (en) 2001-05-17
NZ518252A (en) 2003-10-31
CN1387428A (zh) 2002-12-25
DE60020871T2 (de) 2006-05-11
PT1229900E (pt) 2005-08-31
DE60020871D1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
HU9600574D0 (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor
NZ513810A (en) Compositions and methods for improved delivery of hydrophobic therapeutic agents
DK1372608T3 (da) Medicinske aerosolformuleringer
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AR029623A1 (es) Composiciones farmaceuticas de eritropoyetina
EP0974350A4 (en) EXTERNAL CONTAINING TRANILAST AND METHOD FOR THE PRODUCTION THEREOF
NZ514323A (en) A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent
DE59902270D1 (de) Feuchtigkeitsaktivierbares therapeutisches system
ATE286736T1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
BR0015422A (pt) Formulações de droga de liberação prolongada
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
PT1186292E (pt) Preparados solidos com estrutura multinuclear
ATE230251T1 (de) Lipidmembran zusammensetzungen
MX9707695A (es) Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol.
DE60200317D1 (de) Formulierung mit gesteuerter Wirkstoffabgabe enthaltend Bupropion-HCI als Wirkstoff
AR026436A1 (es) Formulaciones de drogas de liberacion sostenida
AU2000255261A1 (en) Means for maintenance and/or correction of glucose concentration in blood
AR023355A1 (es) Procedimiento de preparacion de globulos con un contenido >/= 50% en peso de sustancia activa farmaceutica

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DAINIPPON PHARMACEUTICAL CO., LTD (JP)

Free format text: TRANSFERIDO DE: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED

B25D Requested change of name of applicant approved

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD. (JP)

Free format text: ALTERADO DE: DAINIPPON PHARMACEUTICAL CO., LTD.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/09/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2330 DE 01-09-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.